NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 313 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,996,035 | -53.4% | 185,513 | +19.6% | 0.00% | -50.0% |
| Q2 2023 | $6,435,698 | -29.5% | 155,077 | +2.2% | 0.00% | -33.3% |
| Q1 2023 | $9,126,367 | -17.2% | 151,752 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $11,018,710 | +76.6% | 150,221 | +82.9% | 0.00% | +50.0% |
| Q3 2022 | $6,240,000 | +4.1% | 82,134 | -4.8% | 0.00% | 0.0% |
| Q2 2022 | $5,994,000 | +2.9% | 86,255 | +22.6% | 0.00% | +100.0% |
| Q1 2022 | $5,826,000 | +28.6% | 70,328 | +16.5% | 0.00% | 0.0% |
| Q4 2021 | $4,531,000 | -73.6% | 60,342 | -59.1% | 0.00% | -75.0% |
| Q3 2021 | $17,136,000 | -68.4% | 147,502 | -39.7% | 0.00% | -69.2% |
| Q2 2021 | $54,289,000 | +228.8% | 244,744 | +95.9% | 0.01% | +225.0% |
| Q1 2021 | $16,512,000 | +45.2% | 124,915 | +90.0% | 0.00% | +33.3% |
| Q4 2020 | $11,374,000 | +524.9% | 65,730 | +302.0% | 0.00% | +200.0% |
| Q3 2020 | $1,820,000 | +13.0% | 16,350 | -39.8% | 0.00% | 0.0% |
| Q2 2020 | $1,611,000 | -96.5% | 27,179 | -96.1% | 0.00% | -95.0% |
| Q1 2020 | $46,509,000 | -42.6% | 690,657 | -28.1% | 0.02% | -20.0% |
| Q4 2019 | $81,002,000 | +92.2% | 961,222 | +70.5% | 0.02% | +127.3% |
| Q3 2019 | $42,150,000 | +11.2% | 563,658 | -6.0% | 0.01% | +10.0% |
| Q2 2019 | $37,903,000 | +109.2% | 599,437 | +59.4% | 0.01% | +66.7% |
| Q1 2019 | $18,116,000 | +157.3% | 376,085 | +78.9% | 0.01% | +100.0% |
| Q4 2018 | $7,040,000 | -58.9% | 210,270 | -35.7% | 0.00% | -40.0% |
| Q3 2018 | $17,148,000 | +460.2% | 327,257 | +234.6% | 0.01% | +400.0% |
| Q2 2018 | $3,061,000 | +65.5% | 97,810 | +15.3% | 0.00% | 0.0% |
| Q1 2018 | $1,849,000 | -63.1% | 84,795 | -65.8% | 0.00% | -50.0% |
| Q4 2017 | $5,008,000 | +49.5% | 247,924 | +47.0% | 0.00% | +100.0% |
| Q3 2017 | $3,349,000 | – | 168,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |